0 likes | 11 Views
Product: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others<br><br>Application: Fungal Infection Therapy, Cancer Tumor Therapy, Others<br><br>Technology: Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome<br><br>End User: Hospitals, Homecare, Others<br><br>The Global Liposomal Market will reach at 8.74 Billion in 2030 and is expected to grow at a CAGR of 8.50% over the forecast period from 2018 to 2030<br><br>To know more: https://www.cognitivemarketresearch.com/liposomal-market-report
E N D